Teva Pharmaceutical Industries (TEVA) Convertible Debt (2009 - 2010)
Teva Pharmaceutical Industries (TEVA) recorded quarterly Convertible Debt of $13.0 million in Q4 2010, down 98.41% on a QoQ basis from $817.0 million in Q4 2009, and down 98.41% year-over-year from $817.0 million in Q4 2009.
Teva Pharmaceutical Industries (TEVA) Convertible Debt (2009 - 2010) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Convertible Debt across 2 years of filings, most recently posting $13.0 million for Q4 2010.
- Quarterly Convertible Debt fell 98.41% year-over-year to $13.0 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $13.0 million (down 98.41% YoY) and the FY2010 annual result came in at $13.0 million, down 98.41% from the prior year.
- Convertible Debt slipped to $13.0 million in Q4 2010, from $817.0 million in the prior quarter.
- Over five years, Convertible Debt peaked at $817.0 million in Q4 2009 and troughed at $13.0 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 13.00 Mn |
| Dec 31, 2009 | 817.00 Mn |